Literature DB >> 16227237

Evolution of a rare vaccine-derived multirecombinant poliovirus.

Ioannis Karakasiliotis1, Eleni Paximadi2, Panayotis Markoulatos2.   

Abstract

Recombination is one of the mechanisms by which viral genomes evolve. A vaccine-derived multirecombinant poliovirus strain was isolated from a 5-month-old child with vaccine-associated paralytic poliomyelitis after oral poliovirus vaccine administration. The isolate had an S2/S1/S2/S1 primary genomic structure as revealed by restriction fragment length polymorphism and sequencing analysis. Recombination of the middle S1/S2 region is extremely rare and one of the few characterized types of recombination with Sabin type 1 as a 5' partner. An attempt was made to perform evolutionary analysis of the contributing sequences using the identified mutations in comparison with the original Sabin sequences. A hypothesis is proposed for the order in which the identified recombination events occurred.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227237     DOI: 10.1099/vir.0.80823-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine.

Authors:  Evaggelos Dedepsidis; Ioannis Karakasiliotis; Eleni Paximadi; Zaharoula Kyriakopoulou; Dimitrios Komiotis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

2.  Partial 3D gene sequences of Coxsackie viruses reveal interspecies exchanges.

Authors:  Eugenia Bolanaki; Christine Kottaridi; Panayotis Markoulatos; Zaharoula Kyriakopoulou; Lukas Margaritis; Theodoros Katsorchis
Journal:  Virus Genes       Date:  2007-02-23       Impact factor: 2.332

3.  Vaccine derived bi- and multi-recombinant Sabin strains.

Authors:  Eleni Paximadi; Ioannis Karakasiliotis; Eugenia Bolanaki; Aris Krikelis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2007-08-07       Impact factor: 2.332

4.  Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.

Authors:  Judith E Mueller; Maël Bessaud; Q Sue Huang; Laura C Martinez; Patricia A Barril; Viviane Morel; Jean Balanant; Judy Bocacao; Joanne Hewitt; Brad D Gessner; Francis Delpeyroux; Silvia V Nates
Journal:  Appl Environ Microbiol       Date:  2009-01-05       Impact factor: 4.792

5.  Genus-specific substitution rate variability among picornaviruses.

Authors:  Allison L Hicks; Siobain Duffy
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

Review 6.  Recombination among human non-polio enteroviruses: implications for epidemiology and evolution.

Authors:  Zaharoula Kyriakopoulou; Vaia Pliaka; Grigoris D Amoutzias; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2014-12-24       Impact factor: 2.332

7.  Full-genome sequence analysis of a multirecombinant echovirus 3 strain isolated from sewage in Greece.

Authors:  Zaharoula Kyriakopoulou; Evaggelos Dedepsidis; Vaia Pliaka; Dimitris Tsakogiannis; Anastassia Pratti; Stamatina Levidiotou-Stefanou; Panayotis Markoulatos
Journal:  J Clin Microbiol       Date:  2010-02-03       Impact factor: 5.948

8.  Growth kinetic analysis of bi-recombinant poliovirus vaccine strains.

Authors:  Vaia Pliaka; Evaggelos Dedepsidis; Zaharoula Kyriakopoulou; Georgia Papadi; Dimitris Tsakogiannis; Anastassia Pratti; Stamatina Levidiotou-Stefanou; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2010-01-21       Impact factor: 2.332

9.  Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses.

Authors:  T G Dimitriou; Z Kyriakopoulou; D Tsakogiannis; A Fikatas; C Gartzonika; S Levidiotou-Stefanou; P Markoulatos
Journal:  Virus Genes       Date:  2016-04-20       Impact factor: 2.332

10.  Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain.

Authors:  Ana Avellón; Maria Cabrerizo; Teresa de Miguel; Pilar Pérez-Breña; Antonio Tenorio; Jose Luis Pérez; Maria Victoria Martínez de Aragón; Gloria Trallero
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.